(2022) Prevalence and impact of coagulation dysfunction in patients with COVID-19 in Yazd. Health Biotechnology and Biopharma. pp. 53-61.
![[img]](http://eprints.ssu.ac.ir/style/images/fileicons/text.png) |
Text
HBB_Volume 6_Issue 1_Pages 53-61.pdf Download (600kB) |
Abstract
Covid-19 patients have coagulation complications resulting in poor prognosis. Therefore, this study aimed to investigate the prevalence of coagulation disorders in patients with Covid-19 admitted to Shahid Sadoughi Hospital in Yazd. This study was a cross-sectional study that all patients admitted with a diagnosis of Covid-19 from the beginning of February 2020 to the end of April 2020 were examined for the frequency of coagulation dysfunctions. A total of 441 patients with Covid-19 were included in the study with a mean age of 55.4 years that 47.8 , 25.6 and 6.8 had impaired Prothrombin Time (PT), Partial Thromboplastin Time (PTT) and International Normalized Ratio (INR), respectively. Copyright © 2022, Health Biotechnology and Biopharma. All rights reserved.
| Item Type: | Article |
|---|---|
| Page Range: | pp. 53-61 |
| Journal or Publication Title: | Health Biotechnology and Biopharma |
| Volume: | 6 |
| Number: | 1 |
| Publisher: | Health Biotechnology And Biopharma |
| Depositing User: | ms soheila Bazm |
| URI: | http://eprints.ssu.ac.ir/id/eprint/12300 |
Actions (login required)
 |
View Item |